SEC Company Response from NOVAVAX INC (NVAX) (CIK 0001000694) (NVAX) — Jan 7, 2020
NOVAVAX INC (NVAX) (CIK 0001000694)
Date: Jan. 7, 2020 · CIK: 0001000694 · Accession: 0001104659-20-001981
AI Filing Summary & Sentiment
File numbers found in text: 333-235761
Letter
NOVAVAX, INC.
21 Firstfield Road
Gaithersburg, MD 20878
January 7, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Novavax, Inc.
Registration Statement on Form S-3 (File No. 333-235761)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Novavax, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-235761) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on January 9, 2020, or as soon as possible thereafter. The Company hereby authorizes Paul Kinsella and Benjamin Kozik of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Benjamin Kozik of Ropes & Gray LLP, counsel to the Company, at (415) 315-6331.
Very truly
yours,
NOVAVAX,
INC.
Show Raw Text
CORRESP
1
filename1.htm
NOVAVAX, INC.
21 Firstfield Road
Gaithersburg, MD 20878
January 7, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Novavax, Inc.
Registration Statement on Form S-3 (File No.
333-235761)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the
Securities Act of 1933, as amended, Novavax, Inc. (the “Company”) hereby requests that the Securities and Exchange
Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on
Form S-3 (File No. 333-235761) (the “Registration Statement”), so that it will be declared effective at 4:00
p.m. Eastern Time on January 9, 2020, or as soon as possible thereafter. The Company hereby authorizes Paul Kinsella and Benjamin
Kozik of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the
Registration Statement is declared effective, you would inform Benjamin Kozik of Ropes & Gray LLP, counsel to the Company,
at (415) 315-6331.
Very truly
yours,
NOVAVAX,
INC.
By:
/s/ John
Herrmann
John Herrmann
Corporate Secretary